MedPath

Use of TrachPhone in Tracheostomized Patients

Not Applicable
Conditions
Tracheostomy
Interventions
Device: TrachPhone HME
Device: External Humidifier (Usual Care)
Registration Number
NCT06487104
Lead Sponsor
Atos Medical AB
Brief Summary

The use of Heat and Moisture Exchangers (HMEs) and their positive impact on pulmonary health have been extensively studied in patients with head and neck cancer but have not been systematically explored in other patient populations breathing through a neck stoma.

The objective of this clinical investigation is to compare the use of HMEs to the use of External Humidifiers (EHs) on pulmonary secretion management, their usability and safety, for humidifying inhaled air in patients that received a tracheostomy due to a neurological condition.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Tracheostomy patient outside critical care
  • Self-ventilating via a tracheostomy tube, independent of cuff status
  • 18 years or older
Exclusion Criteria
  • Patients with tidal volume beyond recommended range (50-1000 ml)
  • Dehydration
  • Very heavy/excessive secretion from the lungs and airways (requiring more frequently tracheal suction, more than hourly suctioning)
  • High oxygen need (FiO2 > 0.4)
  • Acutely deteriorating patient

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm 2 - EHExternal Humidifier (Usual Care)24/7 use of EH until first follow-up (T1), then 24/7 use of TrachPhone HME for the remainder of the study participation.
Arm 1 - HMETrachPhone HME24/7 use of TrachPhone HME for the entirety of study
Arm 2 - EHTrachPhone HME24/7 use of EH until first follow-up (T1), then 24/7 use of TrachPhone HME for the remainder of the study participation.
Primary Outcome Measures
NameTimeMethod
Number of suctioning per dayAt Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

Times per day suctioning is required

Secondary Outcome Measures
NameTimeMethod
Time needed for suctioningAt Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

Minutes per day of suctioning

Quality of Life by EQ-5D-5LAt Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

Patient reported, the descriptive system assesses health in five dimensions, from which a health state index score is calculated, range from 0 to 1, with higher scores indicating higher health utility

Patient preferenceUpon discharge from the hospital (on average after 3 weeks)

% of patients (participants that were assigned to Arm 2) recorded by study specific questionnaire

Use of TrachPhoneAt Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

% of patients using TrachPhone/tolerating TrachPhone recorded by study specific questionnaire

Quality of secretionAt Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

Amount and color of secretion

Nursing time regarding device useAt Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

Minutes per day spent on device handling, recorded by nurse diary keeping, 3-day collection

Adherence to use of devicesAt Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

Hours of use of each humidification method, recorded by study specific questionnaire

Patient communicationAt Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

Communication by Therapy Outcome Measure for Voice Impairment (TOMS, score 0-5, higher score meaning no impairment)

Oxygen needsAt Baseline, T1 follow-up, and TX follow-ups every 10-14 days until discharge

Weaning of oxygen time needed measured by peripheral oxygen saturation (%) recorded in patient charts. Only for monitoring reasons.

Adverse EventsThrough study completion, an average of 1 year

Any incidents reported throughout study duration

Voice QualityAt Baseline, after 10 days, and every 10 days until discharge from hospital (on average after 3 weeks)

Patient reported, for participants speaking, through study specific questionnaire

Patient mobilityUpon discharge of the last participant, on average after 1 year

Staff perception of patient mobility and ease of transportation, measured though study specific questionnaires and nurse survey

Nurse and therapy team feedbackUpon discharge of the last participant, on average after 1 year

Staff impression and preference measured by nurse survey

Trial Locations

Locations (1)

The Royal London Hospital, Barts Health NHS Trust

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath